Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Microbial modulation of diabetes: Short-chain fatty acids (SCFAs) are produced by various human gut microbes. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with type 2 diabetes. Zhao et al. found that adopting a high-fiber diet promoted the growth of SCFA-producing organisms in diabetic humans. The high-fiber diet induced changes in the entire gut microbe community and correlated with elevated levels of glucagon-like peptide-1, a decline in acetylated hemoglobin levels, and improved blood-glucose regulation. Science , this issue p. 1151
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“A lower abundance of SCFA-producing bacteria has been associated with higher risk of type 2 diabetes.89”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [89]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citation
Research works printed but not linked: 3
- Chinese Diabetes Society, China guideline for type 2 diabetes (2013 edition). Chin. J. Diabetes Mellitus 6, 447–498 (2014).
- Y. Yang G. Wang X. Pan China Food Composition (Book 1 Beijing Medical Univ. Press ed. 2 2009).
- H. Wu, R. Wang, Y. Zhao, X. Pang, J. Shen, C. Zhang, ., Exploring carbohydrate utilization capacity of Bifidobacterium pseudocatenulatum isolated from a morbidly obese child after dietary intervention. Genomics Appl. Biol. 34, 1384–1391 (2015).
Cited by
Items 901–1,000 of 1,011
Feng, Y., Zhu, J., Wang, Q., Cao, H., He, F., Guan, Y., Li, D., Yan, J., Yang, J., Xia, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.999715 · Cited by 31
“Since manyspecies inBifidobacteriumare capableofproducingacetic acids with a given amount of carbohydrates, Bifidobacterium is often considered an acetic acid-producing genus (14).”
BackgroundSelf-citationWu, X., Zhao, L., Zhāng, Y., Li, K., & Yang, J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1166685 · Cited by 31
“In the case of DM, hyperglycemia promotes gut microbiota dysbiosis, which contributes to the development of DKD (Fernandes et al., 2019; Iatcu et al., 2021; Mosterd et al., 2021; Nagase et al., 2022; Zhao et al., 2018).”
BackgroundSelf-citationSasaki, H., Hayashi, K., Imamura, M., Hirota, Y., Hosoki, H., Nitta, L., Furutani, A., & Shibata, S. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109420 · Cited by 33
Wang, G., Zhu, G., Chen, C., Zheng, Y., Ma, F., Zhao, J., Lee, Y.-K., Zhang, H., & Chen, W. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0148 · Cited by 38
Large-scale metabolic interaction network of the mouse and human gut microbiota
Lim, R., Cabatbat, J. J. T., Martin, T. L. P., Kim, H., Kim, S.-H., Sung, J., Ghim, C.-M., & Kim, P. (2020) · Scientific Data · doi:10.1038/s41597-020-0516-5 · Cited by 31
Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives
Yuan, L., Li, Y., Chen, M., Xue, L., Wang, J., Ding, Y., Gu, Q., Zhang, J., Zhao, H., Xie, X., et al. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13007-7 · Cited by 30
“Dietary fiber promoted the increase of SCFA-producing strains, increased species diversity and richness, improved glycosylated hemoglobin, and decreased production of harmful compounds such as indoles and hydrogen sulfide in T2DM patients (Zhao et al. 2018).”
Self-citationLiu, S., Meng, F., Sun, R., Li, Y., Li, H., & Liu, B. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.123061 · Cited by 28
Systematically-designed mixtures outperform single fibers for gut microbiota support
Cantu-Jungles, T. M., Agamennone, V., van den Broek, T. J., Schuren, F. H. J., & Hamaker, B. R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2442521 · Cited by 30
Xie, C., Yuan, Y., Wang, Y., Qi, C., Wang, W., An, C., Aikepaer, A., Zhang, Y., Zhang, G., Feng, X., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00673-5 · Cited by 32
“Strategies that modulate the microbiota through diets, prebiotics, pro-biotics, or more targeted microbial therapeutics have recognized as promising approaches to delay or even reverse metabolic disease progression [72].”
Qassab, M. A., Chaarani, N., Hamou, A., Harb, R. M., Jradi, A., Zeineddine, M., Ghadieh, H. E., Khattar, Z. A., Azar, S. T., Kanaan, A., et al. (2026) · FASEB BioAdvances · doi:10.1096/fba.2025-00218 · Cited by 31
“These SCFAs improve insulin sensitivity by reducing inflammation, strengthening gut barrier function, and regulating glucose metabolism through G-protein–coupled receptors [43, 103].”
An empirical Bayes approach to normalization and differential abundance testing for microbiome data
Liu, T., Zhao, H., & Wang, T. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03552-z · Cited by 33
Dietary Fibre, Gut Microbiota Dysbiosis and Type 2 Diabetes
Ojo, O., Feng, Q., Ojo, O. O., & Wang, X. (2020) · International Electronic Conference on Nutrients (IECN) · doi:10.3390/iecn2020-06986 · Cited by 29
“It is possible that the promotion of SCFA producers in terms of greater diversity and abundance by dietary fibre in this review led to an improvement in glycated haemoglobin, partly due to increased glucagon-like peptide-1 (GLP–1) production [12].”
BackgroundSelf-citationStamboulian, M. H., Li, S., & Ye, Y. (2021) · Microbiome · doi:10.1186/s40168-021-01035-8 · Cited by 35
“Of these communities a particular attention has been devoted to the human gut microbiota for its impacts on human health and diseases [5, 6, 7] and its potential applications to improving the efficacy of treatments (including cancer chemotherapy and immunotherapy) [8, 9], and prevention of diseases (e.”
BackgroundChain length‐dependent inulin alleviates diet‐induced obesity and metabolic disorders in mice
Li, L., Zhang, L., Zhou, L., Jin, M., & Xu, L. M. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2283 · Cited by 29
“Our study was partially in agreement with the results by Zhao et al. (Zhao et al., 2018) that intake of a fiber- rich diet for 28 days caused a notable reduction in gut microbiota diversity (gene richness) of patients with type 2 diabetes, which challenged the current notion that greater overall…”
ResultXiao, R., Liao, W., Luo, G., Qin, Z., Han, S., & Lin, Y. C. (2021) · ACS Omega · doi:10.1021/acsomega.1c03485 · Cited by 29
Nuclear receptors: a bridge linking the gut microbiome and the host
Wang, Z., Chen, W., & Wang, Y. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00407-y · Cited by 30
“ADRP: Adipose differentiation‑related protein; AFLD: Alcoholic fatty liver disease; AHR: Aryl hydrocarbon receptor; ALA: α‑Linolenic acid; ALD: Alcoholic liver disease; AMPK: Adenosine monophosphate‑activated protein kinase; ANGPTL4: Angiopoietin‑like 4; ATG16L1: Autophagy related 16 like 1; BAs: Bile acids; BSH: Bile…”
BackgroundInfluentialZhao, Y., Li, M., Wang, Y., Geng, R., Fang, J., Liu, Q., Kang, S., Zeng, W., Huang, K., & Tong, T. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2045895 · Cited by 31
Kong, F., Kang, S., Zhang, J., Zhao, H., Peng, Y., Yang, M., Zheng, Y., Shao, J., & Yue, X. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111454 · Cited by 28
Self-citationQiu, S., Chen, J., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Nutrients · doi:10.3390/nu14132749 · Cited by 30
“Acetic acid, PA, and BA are the most abundant SCFAs in the intestinal tract and can lower the pH of the intestinal tract, enrich beneficial bacteria, and inhibit the growth of harmful bacteria [32].”
BackgroundNi, Y., Zheng, A., Hu, Y., Rong, N., Zhang, Q., Long, W., Yang, S., Nan, S., Zhang, L., Zhou, K., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.959703 · Cited by 50
“Dietary fiber, the well-known prebiotic, has proven to effectively alleviate T2D both in animal and human studies (32).”
BackgroundSelf-citationWei, S., Wang, C., Zhang, Q., Yang, H., Deehan, E. C., Zong, X., Wang, Y., & Jin, M. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120057 · Cited by 30
Self-citationRole of microbiota and microbiota‐derived short‐chain fatty acids in PDAC
TEMEL, H. Y., Kaymak, Ö., Kaplan, S., Bahcivanci, B., Gkoutos, G. V., & Acharjee, A. (2022) · Cancer Medicine · doi:10.1002/cam4.5323 · Cited by 36
Huang, H., Chen, J., Ao, T., Chen, Y., Xie, J., Hu, X., & Yu, Q. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112062 · Cited by 28
Gao, F., Zhang, L., Li, H., Xia, F., Bai, H., Piao, X., Sun, Z., Cui, H., & Shi, L. (2022) · Animals · doi:10.3390/ani12213007 · Cited by 28
“Studies have shown that Lachnospiraceae can promote SCFAs production [55].”
BackgroundShang, J., Cui, W., Guo, R., Zhang, Y., Wang, P., Yu, W., Zheng, X., Wang, T., Dong, Y., Zhao, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.964389 · Cited by 30
“In addition, diet adjustment targeting intest inal bacter ia has great effects on improving hyperglycemia (14).”
BackgroundSelf-citationGut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease
Koshida, T., Gohda, T., Sugimoto, T., Asahara, T., Asao, R., Ohsawa, I., Gotoh, H., Murakoshi, M., Suzuki, Y., & Yamashiro, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411456 · Cited by 32
“Metabolites produced by the microbiome, such as short-chain fatty acids (SCFAs), uremic toxins (UTs), and lipopolysaccharide (LPS), affect human body homeostasis, and are associated with the development and/or progression of chronic kidney disease (CKD) and/or type 2 diabetes [2,3].”
BackgroundInfluentialda Silva, R. S., Mendonça, I. P., de Paiva, I. H. R., de Souza, J. R. B., & Peixoto, C. A. (2023) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2023.2262779 · Cited by 29
“Interestingly, according to previous results, Bacteroides can treat diet-induced metabolic diseases and improve insulin resistance in diabetic mice (Zhao et al. 2018).”
ResultPrebiotics, Probiotics, and Synbiotics—A Research Hotspot for Pediatric Obesity
Balas, R. B., Meliţ, L. E., Lupu, A., Lupu, V. V., & Mărginean, C. O. (2023) · Microorganisms · doi:10.3390/microorganisms11112651 · Cited by 33
“…noticed that individuals receiving high-dietary-fiber supplements for 12 weeks expressed an increased abundance of SCFA-producing bacteria within their gut microbial composition, associated also with improved fasting and postprandial blood glucose levels, as well as hemoglobin A 1c [53] (Table 1).”
BackgroundShi, J., Dong, P., Liu, C., Xu, Y., Zheng, M., Cheng, L., Wang, J., & Raghavan, V. (2023) · Food & Function · doi:10.1039/d3fo03321j · Cited by 28
Self-citationZhang, X., Li, Q., Han, N., Song, C., Lin, Y., Zhang, L., Ren, D., Zhao, Y., Yang, X., & Li, T. (2023) · Food & Function · doi:10.1039/d3fo04215d · Cited by 30
Wei, S., Wang, L., Chen, X., Wang, Y., Tong, L., Han, Q., Ren, B., & Guo, D. (2023) · Food Chemistry X · doi:10.1016/j.fochx.2023.101052 · Cited by 31
“Secondary degrading bacteria then further ferment and degrade the primary degradation products of polysaccharides, resulting in the generation of final metabolites (Zhao et al., 2018).”
BackgroundSelf-citationTlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosis
Wang, P., Yang, X., Zhang, L., Sha, S., Huang, J., Peng, J., Gu, J., Pearson, J. A., Hu, Y., Zhao, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48611-8 · Cited by 32
Role of gut microbial metabolites in nonalcoholic fatty liver disease
Zhao, Z. H., Lai, J. K., Qiao, L., & Fan, J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12709 · Cited by 30
“On the other hand, it has also been shown that a deficiency in SCFA production is associated with type 2 diabetes.(23) Despite the uncoordinated correlation between the SCFA and a dis-”
BackgroundZhao, L., Liu, S., Zhang, Z., Zhang, J., Jin, X., Zhang, J., Jiang, W., Li, H., & Lin, H. (2020) · Adipocyte · doi:10.1080/21623945.2020.1738791 · Cited by 29
“Lowered abundance of universal butyrate- producing bacteria and a deficiency in SCFA production are associated with type 2 diabetes mellitus (T2DM) [6].”
BackgroundSelf-citationHealth Impact and Therapeutic Manipulation of the Gut Microbiome
Daliri, E. B., Ofosu, F. K., Chelliah, R., Lee, B. H., & Oh, D. (2020) · Microarrays · doi:10.3390/ht9030017 · Cited by 28
Xu, D., Fu, L., Pan, D., Lu, Y., Yang, C., Wang, Y., Wang, S., & Sun, G. (2021) · Nutrients · doi:10.3390/nu14010109 · Cited by 27
“suggested that T2DM could be alleviated by dietary fibres, which can be fermented by the gut microbiota and produce the beneficial metabolites of short-chain fatty acids (SCFAs) [15].”
BackgroundHu, W., Wang, Y., Han, J., Zhang, W., Chen, J., Li, X., & Wang, L. (2025) · Biomaterials Science · doi:10.1039/d4bm01273a · Cited by 30
Self-citationHwang, D., Chong, E. G., Li, Y., Li, Y., & Roh, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1553655 · Cited by 31
Medical nutrition therapy for the management of type 2 diabetes mellitus
Barrea, L., Verde, L., Colao, A., Mandarino, L. J., & Muscogiuri, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01161-5 · Cited by 33
The Need for Personalized Approaches to Microbiome Modulation
Jain, N. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00144 · Cited by 29
“A study examining dietary fiber interventions in type 2 diabetes patients found that the microbiomes of positive responders possessed more genes for plant fiber utilization while the microbiomes of negative responders were more enriched in genes for utilization of animal carbohydrates derived from mucin (16).”
BackgroundWatt, R., Parkin, K., & Martino, D. (2020) · Challenges · doi:10.3390/challe11020025 · Cited by 29
Tan, H., & Nie, S. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa065 · Cited by 29
Jin, F., Zhang, J., Shu, L., & Han, W. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00740-2 · Cited by 27
“Finally, in a new randomized controlled trial, Zhao and his colleagues showed that in patients with T2DM a high-fiber diet promotes SCFAproducing gut bacteria, which in turn normalizes levels of HbA1c via an increase in the production of glucagonlike peptide 1 (GLP1) [30].”
BackgroundYe, X., Tang, X., Li, F., Zhu, J., Wu, M., Wei, X., & Wang, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.892801 · Cited by 30
“It is well known that the Lactobacillaceae family and Lactobacillus genus, recognized intestinal probiotics, are beneficial intestinal flora for improvement of intestinal health and exhibit anti-inflammation, antidiabetic, and anti-obesity (43, 44).”
BackgroundLuo, J., Jiang, L., Gao, B., Chai, Y., & Bao, Y. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134569 · Cited by 33
Karim, M. R., Iqbal, S., Mohammad, S., Lee, J. H., Jung, D.-H., Mathiyalagan, R., Yang, D., Yang, D. U., & Kang, S. C. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127346 · Cited by 31
The Alterations of Gut Microbiome and Lipid Metabolism in Patients with Spinal Muscular Atrophy
Feng, Y., Cui, Y., Jin, J., Huang, S., Wei, J., Yao, M., Zhou, D., & Mao, S. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00477-6 · Cited by 31
The Role of Diet and Gut Microbiota Interactions in Metabolic Homeostasis
Guan, L., & Liu, R. (2023) · Advanced Biology · doi:10.1002/adbi.202300100 · Cited by 32
Self-citationGut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers
Lombardi, M., Troisi, J., Motta, B. M., Torre, P., Masarone, M., & Persico, M. (2024) · Nutrients · doi:10.3390/nu16071025 · Cited by 30
“…diet in patients suffering from type-2 diabetes mellitus significantly affects GM fermentation of carbohydrates, promoting a wider diversity and abundance of butyrate-producing bacteria and improving hemoglobin A1c levels, partly through increased glucagon-like peptide-1 (GLP-1) production [35].”
BackgroundLing, Z., Lan, Z., Cheng, Y., Liu, X., Li, Z., Yu, Y., Wang, Y., Shao, L., Zhu, Z., Gao, J., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05533-9 · Cited by 29
Delgado, G., Kleber, M. E., Krämer, B. K., Morcos, M., Humpert, P. M., Wiegand, K., Mauldin, A., Kusterer, K., Enghofer, M., März, W., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0677-6068 · Cited by 28
“Zhao et al. demonstrated that a fibre-enriched diet transforms the gut microbiome and leads to SCFA production [17].”
BackgroundEffects of a Lactulose-Rich Diet on Fecal Microbiome and Metabolome in Pregnant Mice
Zhang, Z., Chen, X., Zhao, J., Tian, C., Wei, X., Li, H., Lin, W., Jiang, A., Feng, R., Yuan, J., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01479 · Cited by 27
The gut microbiota: a new perspective on the toxicity of malachite green (MG)
Li, T., Tian, D., Zhu, Z., Jin, W., Wu, S., & Li, H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10214-5 · Cited by 28
“The diversity and composition of the gut microbial community have been linked to various immune and metabolic parameters (lipopolysaccharide-binding protein, inflammatory cytokines, blood glucose, etc.) (Claesson et al. 2012; Graessler et al. 2013; Zhang et al. 2013; Zhao et al. 2018).”
BackgroundMa, X., Yan, H., Hong, S., Yu, S., Gong, Y., Wu, D., Li, Y., & Xiao, H. (2023) · Nutrients · doi:10.3390/nu15020456 · Cited by 27
“Recent studies have demonstrated that interactions between the host and gut microbiota can affect many aspects of energy metabolism [41].”
BackgroundChen, M., Qiao, Y., Yu, L., Wang, W., Wang, W., Sun, H., Xu, Y., Bai, J., Zhou, J., & Geng, D. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.017 · Cited by 52
“The local infection microenvironment surrounding the implant tends to become acidic due to the organic acids produced by bacterial metabolism [44,45], prompting SF to exhibit a pH-responsive role.”
BackgroundSelf-citationDicks, L. M. T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910634 · Cited by 29
“In volunteers with type 2 diabetes, dietary-driven microbial production of SCFAs correlated with clinical improvement in blood glucose control, an increase in GLP-1, and a reduction in acetylated hemoglobin [86].”
BackgroundWu, X., Tjahyo, A. S., Volchanskaya, V. S. B., Wong, L. H., Lai, X., Yong, Y. N., Osman, F., Tay, S. L., Govindharajulu, P., Ponnalagu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56084-6 · Cited by 35
Song, D., Feng, G., Ma, Y., Shi, Y., Qian, C., Wang, C., Xu, J., Li, Y., Wang, X., Fan, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66498-x · Cited by 31
“Our previous study has demonstrated that dietary fi ber selectively promotes a speci fi c group of bacteria to produce acetate and butyrate, leading to increased levels of GLP-1 and enhanced insulin secretion, which is the mechanisms of dietary fi ber improves glycemic control 19 .”
InfluentialSelf-citationHunt, J. E., Hartmann, B., Schoonjans, K., Holst, J. J., & Kissow, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640602 · Cited by 29
“The present results agree with previous studies assessing Lcell secretion following fiber supplement in rodents and humans (3) (45) (46).”
ResultGut microbiome and its potential link to personalized nutrition
Kviatcovsky, D., Zheng, D., & Elinav, E. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.05.002 · Cited by 28
Lyu, Z., Yu, T., Zhang, L., Xu, X., Zhang, Y., Li, J., Li, Z., Zhang, W., & Hou, S. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.11.002 · Cited by 27
Exercise for the Diabetic Gut—Potential Health Effects and Underlying Mechanisms
Valder, S., & Brinkmann, C. K. (2022) · Nutrients · doi:10.3390/nu14040813 · Cited by 29
“Usually, these SCFAs result from the microbial fermentation of nondigestible carbohydrates, such as cellulose, pectin, and oligosaccharides [23,40,42].”
BackgroundZhang, L., Ko, C., & Zeng, Y.-M. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s354742 · Cited by 26
Self-citationKynkäänniemi, E., Lahtinen, M. H., Jian, C., Salonen, A., Hatanpää, T., Mikkonen, K. S., & Pajari, A. (2022) · Food & Function · doi:10.1039/d1fo03922a · Cited by 27
Zhao, M., Cui, W., Hu, X., & Ma, Z. (2022) · Food & Function · doi:10.1039/d1fo04354d · Cited by 26
Research Progress on Hypoglycemic Mechanisms of Resistant Starch: A Review
Liu, J., Lu, W., Liang, Y., Wang, L., Jin, N., Zhao, H., Fan, B., & Wang, F. (2022) · Molecules · doi:10.3390/molecules27207111 · Cited by 28
“Additionally, the metabolites of intestinal microbiota can improve the intestinal barrier, reduce the IR and the expression of the related inflammatory factors [38].”
BackgroundSelf-citationChen, G., Xu, Y., Zhang, H., Muema, F. W., & Guo, M. (2023) · Food Frontiers · doi:10.1002/fft2.238 · Cited by 28
Self-citationGunadhar, P., Goodwin, S. M., Livingston, K. A., & Karlsen, M. C. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231181574 · Cited by 28
Microbiota dynamics preceding bariatric surgery as obesity treatment: a comprehensive review
Zambrano, A. K., Paz‐Cruz, E., Ruiz‐Pozo, V. A., Cadena-Ullauri, S., Tamayo‐Trujillo, R., Guevara‐Ramírez, P., Zambrano-Villacres, R., & Simancas‐Racines, D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1393182 · Cited by 27
“Furthermore, the gut microbiota produces metabolites that play critical roles in lipid metabolism, energy expenditure, and inflammation, thus shaping the metabolic phenotype of the host (31, 41, 42).”
BackgroundZhou, X., Chen, R., Zhong, C., Wu, J., Li, X., Li, Q., Cui, W., Yi, N., Xiao, M., Yin, H., et al. (2018) · Nutrition · doi:10.1016/j.nut.2018.09.022 · Cited by 31
Epidemiology, risk factors across the spectrum of age-related metabolic diseases
Deng, X., Wang, P., & Yuan, H. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126497 · Cited by 29
Fu, Z., Jia, Q., Zhang, H., Kang, L., Sun, X., Zhang, M., Wang, Y., & Hu, P. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462680 · Cited by 27
Self-citationXu, X., Zhang, F., Ren, J., Zhang, H., Jing, C., Wei, M., Jiang, Y., & Xie, H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1243095 · Cited by 27
“Only three studies (13, 19, 20) explicitly mentioned using random sequence generation for allocation, and two of these studies (13, 19) also reported concealing the allocation scheme, indicating low risk of selection bias.”
BackgroundInfluentialSelf-citationGut Feelings: How Microbes, Diet, and Host Immunity Shape Disease
Theis, B. F., Park, J. S., Kim, J. S., Zeydabadinejad, S., Vijay–Kumar, M., Yeoh, B. S., & Saha, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061357 · Cited by 25
Wang, G., Liu, Q., Pei, Z., Wang, L., Tian, P., Liu, Z., Zhao, J., Zhang, H., & Chen, W. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01088 · Cited by 31
“Compared with other Bifidobacterium species, B. pseudocatenulatum has been shown to be significantly associated with metabolic diseases in both animal experiments (Agusti et al., 2018) and clinical trials (Wu et al., 2017; Zhao et al., 2018).”
ResultSelf-citationThe gut microbiota and its products: Establishing causal relationships with obesity related outcomes
Li, L., Zhang, Y., Speakman, J. R., Hu, S., Song, Y., & Qin, S. (2021) · Obesity Reviews · doi:10.1111/obr.13341 · Cited by 27
Wu, W., Zhou, D., Xuan, R., Zhou, J., Liu, J., Chen, J., Han, H. L., Niu, T., Li, X., Chen, H., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105940 · Cited by 26
Zeng, Q., Zhao, M., Wang, F., Li, Y., Li, H., Zheng, J., Chen, X., Zhao, X., Liang, J., Gao, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.906310 · Cited by 27
“(42) found that adopting a high-fiber diet promoted the growth of SCFA-producing species including Bifidobacterium longum in diabetic humans, in company with the elevated levels of glucagon-like peptide-1, a decline in hemoglobin A1c levels, and improved blood glucose levels.”
BackgroundLiu, J., Wang, X., Xie, H., Zhong, Q., & Xia, Y. (2022) · Genome · doi:10.1139/gen-2021-0120 · Cited by 35
Self-citationNiu, Z., Zou, M., Bei, T., Zhang, N., Li, D., Wang, M., Li, C., & Tian, H. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.063 · Cited by 25
Meijer, J. L., Roderka, M. N., Chinburg, E. L., Renier, T. J., McClure, A. C., Rothstein, R. I., Barry, E. L., Billmeier, S. E., & Gilbert-Diamond, D. (2022) · Nutrients · doi:10.3390/nu14204243 · Cited by 29
“For instance, SCFAs play a vital role in communication across the gut-brain axis, stimulating the production of glucagon-like peptide-1 [42], which in turn stimulates insulin secretion and suppresses appetite [43].”
BackgroundFrąk, M., Grenda, A., Krawczyk, P. A., Milanowski, J., & Kalinka‐Warzocha, E. (2022) · Cancers · doi:10.3390/cancers14225577 · Cited by 28
Qayyum, N., Wang, S., Yantin, Q., Wang, R., Wang, S., Ismael, M., & Lü, X. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102404 · Cited by 25
ALZHEIMER’S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS
Faulin, T. D. E. S., & Estadella, D. (2023) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202301000-17 · Cited by 30
“…known that the intestinal microbiota plays several roles in the host, such as: enzyme production (44) , immune system development (45) , influence on circadian rhythm (46) , vitamin production (47) , nutrient metabolism (48) , reduced insulin resistance (49) and protection against pathogens (50) .”
BackgroundXiao, R., Wang, L., Tian, P., Jin, X., Zhao, J., Zhang, H., Wang, G., & Zhu, M. (2023) · Nutrients · doi:10.3390/nu15143240 · Cited by 27
“Synergistic interactions between probiotic strains may account for this effect, and they may be the result of functional groups interacting with one another to enhance the host’s glycaemic parameters [6].”
BackgroundSelf-citationBendriss, G., MacDonald, R. S., & McVeigh, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511978 · Cited by 55
Huang, P., Dong, Q., Wang, Y., Tian, Y., Wang, S., Zhang, C., Yu, L., Tian, F., Gao, X., Guo, H., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100559 · Cited by 32
Self-citationUnraveling anti-aging mystery of green tea in C. elegans: Chemical truth and multiple mechanisms
Ke, J., Li, J.-Y., Yang, Z. M., Wu, H.-Y., Yu, J.-Y., Yang, Y., Chen, C., Zhou, P., Hua, F., Wang, W., et al. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.140510 · Cited by 28
de Jonge, C., Fuentes, S., Zoetendal, E. G., Bouvy, N. D., Nelissen, R. M. E. H., Buurman, W. A., Greve, J.-W. M., de Vos, W. M., & Rensen, S. S. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0336-x · Cited by 26
“A specific fiber treatment that affected the intestinal microbiota was also shown to improve insulin resistance [23].”
Sudun, S., Liu, S., Xiao, C., Peng, C., Liang, L., He, X., Zhao, S., & Zhang, G. (2019) · Food & Function · doi:10.1039/c9fo00444k · Cited by 26
Establishment of an efficient germ-free animal system to support functional microbiome research
Li, J., & Wei, H. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-9832-9 · Cited by 27
Self-citationWang, C., Dang, T., Baste, J., Joshi, A. A., & Bhushan, A. (2021) · The FASEB Journal · doi:10.1096/fj.202001600rr · Cited by 27
“, 2011; Oz, 2017) or indirectly affect important functions (Kaska et al., 2016; Melican et al., 2008; Zhao et al., 2018) such as protection”
BackgroundZhang, F., Wang, W., Nie, Y., Li, J., & He, X. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14317 · Cited by 25
Self-citationGut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
Bioactive Polysaccharides Targeting Gut Microbiota to Modulate Host Health: A Gear Effect Theory
Sun, Y., Zhang, S., Yin, J., & Nie, S. (2025) · Food Frontiers · doi:10.1002/fft2.70048 · Cited by 25
Kanbay, M., Al-Shiab, R., Shah, E., Özbek, L., Güldan, M., Ortíz, A., & Fouque, D. P. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf351 · Cited by 28
“Gut dysbiosis is often linked with metabolic diseases such as obesity, insulin resistance, and T2DM and usually characterized by profoundly impaired microbial diversity and function [8 ].”
Santiago-Rodríguez, T. M., Garoutte, A., Adams, E., Nasser, W., Ross, M. C., Reau, A. L., Henseler, Z. M., Ward, T., Knights, D., Petrosino, J. F., et al. (2020) · Genes · doi:10.3390/genes11111380 · Cited by 25
Rhys-Jones, D. R., Climie, R. E., Jama, H., Gill, P. A., Head, G. A., Gibson, P., Kaye, D. M., Muir, J. G., Mackay, C., & Marques, F. Z. (2021) · Trials · doi:10.1186/s13063-021-05468-2 · Cited by 25
Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps
Furthner, D., Weghuber, D., Dalus, C., Lukas, A., Ladenhauf, H. N., Mangge, H., & Pixner, T. (2021) · Hormone Research in Paediatrics · doi:10.1159/000518595 · Cited by 28
Rong, B., Wu, Q., Saeed, M., & Sun, C. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.09.009 · Cited by 28
“For instance, in a previously mentioned investigation, Wei et al. (2018a) found that intermittent administration with absent leucine maintained the physiological function of the pancreas islet while it increased the hepatic lipid accumulation and changed body composition.”
BackgroundInfluential
Metadata
- Authors
- Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., Dong, W., Liu, R., Ling, Y., Zeng, Y., Wang, X., Zhang, Q., Wang, J., Wang, L., Wu, Y., Zeng, B., Wei, H., Zhang, M., Peng, Y., & Zhang, C.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Shanghai Jiao Tong University (CN)
- Sijing Community Health Service Center of Songjiang District, Shanghai 201601, China.
- Sijing Hospital of Songjiang District, Shanghai 201601, China.
- Department of Endocrinology and Metabolism, Qidong People’s Hospital, Jiangsu 226200, China.
- Army Medical University (CN)
- Corresponding author
- Zhao, Liping
- Zhang, Feng
- Ding, Xiaoying
- Wu, Guojun
- Lam, Yan Y.
- Peng, Yongde
- Zhang, Chenhong
- ORCID
- Venue
- Science
- Published
- 2018-03-09
- Volume
- 359
- Issue
- 6380
- Pages
- 1151-1156
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2789495752
- Cited by
- 2,304
- References
- 63
- Citations by year
- 2026: 208 · 2025: 286 · 2024: 270 · 2023: 301 · 2022: 347 · 2021: 307 · 2020: 285 · 2019: 216 · 2018: 81
- FWCI
- 79.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31330005, 81401141, 81370904)
- Science and Technology Commission of Shanghai Municipality (14YF1402200)
- Key Projects of Shanghai Municipal Health Bureau Research Fund (201440033)
- Shanghai Jiao Tong University Research Funding on Medical and Engineering Interdisciplinary Projects (YG2015ZD08)
- Songjiang District Health Bureau of Climbing Medical Program (0702N14003)
- Shanghai Shen Kang Hospital Development Center for chronic disease prevention and control project (SHDC12015304)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, dietary fiber, short-chain fatty acids, SCFA-producing bacteria, fecal microbiota transplantation, glucagon-like peptide-1, HbA1c, indole, hydrogen sulfide, carbohydrate fermentation, isocaloric diet
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, China, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Fatty Acids, Volatile, Feces, Female, Fermentation, Glycated Hemoglobin, Humans, Hydrogen Sulfide, Indoles, Male, Middle Aged, Glucagon-Like Peptide 1, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.